T-lymphoblastic lymphoma with cutaneous involvement
被引:0
|
作者:
Emmanuelle Ginoux
论文数: 0引用数: 0
h-index: 0
机构:
Department of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de LyonDepartment of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
Emmanuelle Ginoux
[1
,2
]
Fanny Julia
论文数: 0引用数: 0
h-index: 0
机构:
Department of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de LyonDepartment of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
Fanny Julia
[1
,2
]
Brigitte Balme
论文数: 0引用数: 0
h-index: 0
机构:Department of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
Brigitte Balme
[3
]
Luc Thomas
论文数: 0引用数: 0
h-index: 0
机构:
Department of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de LyonDepartment of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
Luc Thomas
[1
,2
,4
]
Stéphane Dalle
论文数: 0引用数: 0
h-index: 0
机构:
Department of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de LyonDepartment of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
Stéphane Dalle
[1
,2
,4
]
机构:
[1] Department of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
To study dermatological manifestation of T-lymphoblastic lymphoma and to help clinicians in the diagnosis, we report here the case of a 75-year-old patient who presented with violaceous nodules acquired during the last 4 wk and affecting the scalp and right arm. The diagnosis of systemic lymphoma was suggested upon the appearance of cutaneous tumors, palpable lymph nodes and general symptoms including asthenia and weight-loss. The pathology features: positive immunostaining for CD3 and terminal deoxynucleotidyl transferase(Td T) and staging, led us to the final diagnosis of T-lymphoblastic lymphoma(T-LBL) with cutaneous involvement. He received a CHOP regimen as first-line treatment. Unfortunately, the patient relapsed and died 8 mo after the treatment initiation. T-LBL may be diagnosed by skin lesions. Additional immunostaining including Td T and experienced histopathologists are needed to correctly classify this aggressive disease and discuss the correct management including bone-marrow transplantation where appropriate.